What antidepressant has the least sexual side effects for a patient?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: January 13, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Antidepressant with Least Sexual Side Effects

Bupropion is the antidepressant with the lowest risk of sexual dysfunction and should be your first-line choice when sexual side effects are a concern. 1, 2

Primary Recommendation

  • Bupropion causes significantly less sexual dysfunction than all SSRIs and SNRIs, with sexual dysfunction rates of only 15% in men and 7% in women, compared to 63% and 41% respectively with sertraline 3
  • The American College of Physicians explicitly recommends selecting bupropion over fluoxetine and sertraline when sexual adverse events are a concern 1, 2
  • Bupropion demonstrated superior sexual tolerability across all categories of sexual dysfunction (libido, arousal, orgasm) in both men and women 4, 5

Dosing Strategy for Bupropion

  • Start with bupropion SR 150 mg daily, which can be titrated up to 300-400 mg/day as needed for antidepressant efficacy 2, 3
  • Most improvement in sexual function occurs within the first 2 weeks at low doses (100-200 mg/day) 4
  • The sustained-release formulation is preferred for better tolerability 6, 3

Critical Safety Consideration: Seizure Risk

  • Bupropion carries an increased seizure risk, particularly at doses above 300 mg/day 1, 2
  • Absolute contraindications include: seizure disorders, bulimia/anorexia nervosa, and abrupt discontinuation of alcohol or benzodiazepines 2
  • Use caution in patients with predisposing factors for seizures 2

If You Must Use an SSRI

When bupropion is contraindicated or ineffective for depression (e.g., comorbid anxiety disorders where SSRIs are preferred), the hierarchy for lowest sexual dysfunction is:

  1. Escitalopram or fluvoxamine - lowest sexual dysfunction rates among SSRIs 7
  2. Sertraline or citalopram - intermediate rates (sertraline: 14% in males, 6% in females) 7
  3. Fluoxetine - moderate-high rates 7
  4. Paroxetine - highest rates at 70.7%, should be avoided entirely when sexual function matters 7

Avoid These Medications

  • Paroxetine has the worst sexual dysfunction profile of all antidepressants and should never be used when sexual function is a concern 1, 7
  • SNRIs (venlafaxine, duloxetine, desvenlafaxine) impair sexual function and should be avoided when libido is a priority 2, 7

Common Pitfalls

  • Sexual dysfunction rates are substantially underreported in clinical trials, so real-world incidence is likely higher than published figures 2, 7
  • Sexual dysfunction can emerge as early as day 7 of SSRI treatment at starting doses 3
  • Don't combine bupropion with MAO inhibitors 6
  • Monitor for therapeutic response within 1-2 weeks and adjust if no adequate response by 6-8 weeks 2, 7

Managing Existing SSRI-Induced Sexual Dysfunction

If a patient is already on an SSRI with sexual dysfunction:

  • Switch to bupropion as the primary strategy 2
  • Alternatively, add bupropion SR to the existing SSRI at escalating doses up to 300 mg daily, with most improvement occurring within 2 weeks 4
  • For men with erectile dysfunction specifically, adding a PDE5 inhibitor (sildenafil or tadalafil) is robustly supported, but never use with nitrates 2

References

Guideline

Antidepressants with Lesser Sexual Dysfunction Side Effects

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

SSRIs and Sexual Dysfunction in Men: Medication Selection

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Bupropion: pharmacology and therapeutic applications.

Expert review of neurotherapeutics, 2006

Guideline

Antidepressant-Associated Sexual Dysfunction and Insomnia

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.